期刊文献+

急性心力衰竭患者预后评估及其相关影响因素分析 被引量:5

Prognosis evaluation and correlated influencing factors of acute heart failure patients
下载PDF
导出
摘要 目的:探讨急性心力衰竭(AHF)患者预后评估及其相关危险因素。方法:将210例急性心力衰竭患者依据随访结果分为事件组(45例)和非事件组(165例),收集各种临床资料,采用单因素比较和多因素Logistic回归来筛选可能影响AHF预后不良的危险因素。结果:AHF患者随访6个月内的预后不良率为21.43%(45/210);多因素分析显示,AHF预后不良的影响因素包括下肢水肿(OR=4.088)、心功能分级(OR=3.203)、LVEF(OR=0.535)、NT-proBNP(OR=1.234)及其cTnⅠ(OR=5.430)。结论:AHF患者的预后不良事件发生率仍然较高,其独立危险因素包括下肢水肿、心功能分级高、左心室射血分数低、较高水平的NT-proBNP和cTnⅠ,应综合考虑这些独立危险因素对患者进行早期评估。 [Objective]To explore prognosis evaluation and correlated influencing factors of acute heart failure(AHF)patients. [Method]210 AHF patients were divided into event group(45 cases) and non-event group(165 cases) according to following up result,and different clinical data was collected. Single factor comparison and multiple factors Logistic regression method were used to screen the risk factors of bad prognosis of AHF. [Result]The prognosis rate of AHF within 6 months after follow-up was 21. 43%(45/210). Multiple factors analysis showed that the influencing factors of bad prognosis of AHF included in edema of lower extremity(OR = 4. 088),cardiac functional grading(OR =3. 203),LVEF(OR = 0. 535),NT-proBNP(OR = 1. 234) and cTnⅠ(OR = 5. 430). [Conclusion]The rate of bad prognosis of AHF lies a high level. Its independent risk factors contain edema of lower extremity,cardiac functional grading,low level of LVEF,high levels of NT-proBNP and cTnⅠ. So we should comprehensively think of these independent risk factors and early evaluate patient's condition.
出处 《浙江医学教育》 2018年第1期28-30,共3页 Zhejiang Medical Education
关键词 急性心力衰竭 预后评估 危险因素 acute heart failure prognosis evaluation risk factors
  • 相关文献

参考文献6

二级参考文献64

  • 1王俊利,周晓芳.老年心力衰竭目前认识与治疗进展[J].实用医院临床杂志,2007,4(1):86-88. 被引量:5
  • 2井娜,孙海宁,车至香.心肌损伤标志物与心力衰竭[J].心血管康复医学杂志,2007,16(1):101-102. 被引量:9
  • 3Lee DS,Austin PC,Rouleau JL,et al.Predicting mortality among patients hospitalized for heart failure:derivation and validation of a clinical model[J].JAMA,2003,90(19):2581-2587.
  • 4Hladik A,Lynshue K.Dyshemoglobinemias and pulse oximetry:a therapeutic challenge[J].Pediatr Hematol Oncol,2008,30(11):850-852.
  • 5孙红.N-末端脑钠肽前体及心肌肌钙蛋白I与慢性心力衰竭的关系[J].中国中西医结合杂志,2011,18(4):235-236.
  • 6Zhang J,Guy MJ,Norman HS,et al.Top-down quantitative pro-teomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure[J].J Proteome Res,2011,10(9):4054-4065.
  • 7Mcmurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treartment of Acute and Chronic Heart Failure 2012 of the Europen Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) ofthr ESC[J]. Eur Heart, 2012, 33(14) 1787-1847.
  • 8Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome[J]. Am Coil Cardiol, 2008, 52(19): 1527-1539.
  • 9Weintraub NL, Collins SP, Pang PS, et al. Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association[J]. Circulation, 2010, 122(19): 1975-1996.
  • 10Fonarow GC, Peacock WF, Phillips CO, et al. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure[J]. J Am Coil Cardiol, 2007, 49( 19): 1943-1950.

共引文献4728

同被引文献39

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部